OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Gastroenterology and Hepatology is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial Board	541
Front Cover	432
Hepatic Artery Pseudoaneurysm After Whipple Procedure	309
Table of Contents	303
Blue Notes	279
Editorial Board	243
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	224
Blue Notes	217
FODMAPs in IBS: Revisiting Restriction	204
Elsewhere in the AGA Journals	195
Reply	192
Editorial Board	187
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	186
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	179
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	168
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	166
Reply	145
Attribution of Colonoscopy Risk Does Not FIT!	142
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	140
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	136
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	132
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	131
Chronic Kidney Disease Does Not Influence Response to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury	127
Who Examines the Colon Matters More Than What Is Removed	126
Perianal Disease in Pediatric-onset Crohn’s Disease: Incidence, Disease Course, and Long-term Outcomes	122

Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	121
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	120
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	118
Correction	118
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	114
Table of Contents	114
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	111
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	111
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	110
Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial	108
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	108
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	106
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	105
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	102
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	99
Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection	97
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	96
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	96
Assessment and Significance of Histologic Activity in Crohn’s Disease	93
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	92
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient in Clinical Practice: An Investigational Procedure—What Can We Tell Patients?	91
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	90
Symptom-Based Testing and Eradication of Helicobacter pylori and Risk of Gastric Cancer	87
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	87
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	87
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	86
Hepatic Steatosis Is Associated With Increased Cardiovascular Risk Through Adverse Coronary Plaque Composition	86
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	86
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease	86
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	85
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	85
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	84
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	83
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	83
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	81
AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study	80
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	79
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	79
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	78
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	78
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	78
Associations Between Sexual Orientation and Disorders of Gut-Brain Interaction in Sexual Minority Populations	77
Hypermobile Ehlers-Danlos Syndrome and the Nosology of Disorders of Gut-Brain Interaction	77
Reply	77
Front Cover	77
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	76
Blue Notes	76
Association Between Index Adenomas and Advanced Findings at Third Colonoscopy: Data From the New Hampshire Colonoscopy Registry	75
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	75
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	74